Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA cautions against excessive pre-formed vitamin A intake by women of child-bearing age.

This article was originally published in The Tan Sheet

Executive Summary

PRE-FORMED VITAMIN A INTAKE LIMITATION TO 100% OF DAILY VALUE was recommended by FDA in an Oct. 6 "Talk Paper." The "Talk Paper" was issued in response to a recently-released New England Journal of Medicine study linking high levels of retinol (pre-formed) vitamin A consumption in pregnant women to an increased incidence of birth defects . The FDA document stresses that the study "raises serious public health concerns."

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS084363

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel